Deadline on January 5th coming up for Investors in shares of Neovasc Inc. (NASDAQ: NVCN)

A deadline is coming up on January 5, 2021 in the lawsuit filed for certain investors of Neovasc Inc. (NASDAQ: NVCN) over alleged securities laws violations by Neovasc Inc.

Investors who purchased shares of Neovasc Inc. (NASDAQ: NVCN) have certain options and there are strict and short deadlines running. Deadline: January 5, 2021. NASDAQ: NVCN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges on behalf of purchasers of Neovasc Inc. (NASDAQ: NVCN) common shares between November 1, 2019 and October 27, 2020, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between November 1, 2019 and October 27, 2020, the Defendants failed to disclose to investors that the results of COSIRA, Neovasc’s clinical study for the Reducer, contained imbalances in missing information present in the control group versus the treatment group, including significant missing information for secondary endpoints but none for the primary endpoint, that the imbalance in missing information indicated that control subjects were aware of their treatment assignment (not blinded) and less inclined to participate in additional data collection, that blinding is critical when studying a placebo-responsive condition such as angina, that the lack of blinding assessment made the primary endpoint difficult to interpret, that, as a result of the foregoing, the FDA was reasonably likely to require additional premarket clinical data, that, as a result, the Company’s PMA for Reducer was unlikely to be approved without additional clinical data, and that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Neovasc Inc. (NASDAQ: NVCN) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.